metricas
covid
Buscar en
Revista de Psiquiatría y Salud Mental
Toda la web
Inicio Revista de Psiquiatría y Salud Mental Neuroimaging correlates of insight in non-affective psychosis: A systematic revi...
Información de la revista
Vol. 15. Núm. 2.
Páginas 117-133 (abril - junio 2022)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
1378
Vol. 15. Núm. 2.
Páginas 117-133 (abril - junio 2022)
Review
Acceso a texto completo
Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis
Revisión sistemática y metaanálisis en neuroimagen y conciencia de enfermedad en psicosis no afectivas
Visitas
1378
Pau Soldevila-Matíasa,b,c,1, Georgios Schoretsanitisd,1, Diana Tordesillas-Gutierreze,f,g,
Autor para correspondencia
diana.tordesillas@idival.org

Corresponding author.
, Manuel J. Cuestah,i, Renato de Filippisd,j, Rosa Ayesa-Arriolae,f,g, Carlos González-Vivasb, Esther Setién-Sueroe,f,g, Norma Verdolinik, Julio Sanjuánb,g,l, Joaquim Raduag,m,n,o,2, Benedicto Crespo-Facorroe,f,g,2
a Department of Basic Psychology, Faculty of Psychology, University of Valencia, Valencia, Spain
b Research Institute of Clinic University Hospital of Valencia (INCLIVA), Valencia, Spain
c National Reference Center for Psychosocial Care for People with Serious Mental Disorder (CREAP), Valencia, Spain
d The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York, USA
e Marqués de Valdecilla University Hospital, Department of Radiology, IDIVAL, Santander, Spain
f Marqués de Valdecilla University Hospital, Department of Psychiatry, School of Medicine, University of Cantabria, IDIVAL, Santander, Spain
g CIBERSAM, Biomedical Research Network on Mental Health Area, Madrid, Spain
h Department of Psychiatry, Complejo Hospitalario de Navarra, Pamplona, Spain
i IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
j Psychiatry Unit Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro 88100, Italy
k Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, 170 Villarroel Street, 12-0, 08036 Barcelona, Spain
l Department of Psychiatric, University of Valencia, School of Medicine, Valencia, Spain
m Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
n Centre for Psychiatric Research and Education, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
o Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Ver más
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (2)
Abstract
Objective

Neurological correlates of impaired insight in non-affective psychosis remain unclear. This study aimed to review and meta-analyze the studies assessing the grey matter volumetric correlates of impaired insight in non-affective psychosis.

Methods

This study consisted of a systematic review of 23 studies, and a meta-analysis with SDM-PSI of the 11 studies that were whole-brain and reported maps or peaks of correlation of studies investigating the grey matter volumetric correlates of insight assessments of non-affective psychosis, PubMed and OVID datasets were independently reviewed for articles reporting neuroimaging correlates of insight in non-affective psychosis. Quality assessment was realized following previous methodological approaches for the ABC quality assessment test of imaging studies, based on two main criteria: the statistical power and the multidimensional assessment of insight. Study peaks of correlation between grey matter volume and insight were used to recreate brain correlation maps.

Results

A total of 418 records were identified through database searching. Of these records, twenty-three magnetic resonance imaging (MRI) studies that used different insight scales were included. The quality of the evidence was high in 11 studies, moderate in nine, and low in three. Patients with reduced insight showed decreases in the frontal, temporal (specifically in superior temporal gyrus), precuneus, cingulate, insula, and occipital lobes cortical grey matter volume. The meta-analysis indicated a positive correlation between grey matter volume and insight in the right insula (i.e., the smaller the grey matter, the lower the insight).

Conclusion

Several brain areas might be involved in impaired insight in patients with non-affective psychoses. The methodologies employed, such as the applied insight scales, may have contributed to the considerable discrepancies in the findings.

Keywords:
Grey matter
Non-affective psychosis
Insight
Magnetic resonance imaging (MRI)
Neuroimaging
Resumen
Objetivo

Los correlatos neurológicos de la conciencia de enfermedad en psicosis no afectivas siguen sin estar claros. Este estudio tiene como objetivo revisar y metaanalizar los estudios que evalúan los correlatos volumétricos de la materia gris de la conciencia de enfermedad deficiente en la psicosis no afectiva.

Métodos

Este estudio consistió en una revisión sistemática de 23 estudios y un metaanálisis con SDM-PSI de los 11 estudios que examinaron todo el cerebro y reportaron mapas o picos de correlación de estudios que investigan los correlatos volumétricos de materia gris de evaluaciones de insight de psicosis no afectiva. Los conjuntos de datos de PubMed y OVID se revisaron de forma independiente para los artículos que informaban sobre correlaciones de neuroimagen de insight en psicosis no afectiva. La evaluación de la calidad de los estudios de imagen se realizó siguiendo enfoques metodológicos previos usando la prueba de evaluación de la calidad ABC basados en dos criterios principales: el poder estadístico y la evaluación multidimensional del insight. Los picos de correlación del estudio entre el volumen de materia gris y la conciencia de enfermedad fueron utilizados para recrear mapas de correlación cerebral.

Resultados

Se incluyeron veintitrés estudios de imágenes por resonancia magnética (IRM) que utilizaron diferentes escalas de conciencia de enfermedad. La calidad de los estudios revisados fue clasificada como alta en 11 estudios, moderada en 9 estudios y baja en 3 estudios. Los pacientes con insight reducido mostraron disminuciones en el volumen de materia gris cortical de los lóbulos frontal, temporal (específicamente en la circunvolución temporal superior), precúneo, cingulado, ínsula y lóbulo occipital. El metaanálisis mostró una correlación positiva entre el volumen de materia gris y la conciencia de enfermedad en la ínsula derecha (es decir, cuanto más pequeña es la materia gris, menor es el insight).

Conclusiones

Varias áreas del cerebro pueden estar involucradas en la conciencia de enfermedad en pacientes con psicosis no afectivas. Tanto las metodologías empleadas como las escalas para valorar la conciencia de enfermedad aplicadas pueden haber contribuido a las considerables discrepancias en los hallazgos publicados.

Palabras clave:
Materia gris
Psicosis no afectiva
Conciencia de enfermedad
Imagen por resonancia magnética
Neuroimagen
Texto completo
Introduction

Schizophrenia is a severe psychiatric disorder characterized by positive (delusions and hallucinations) and negative symptoms (affect, anhedonia, avolition, alogia, and social withdrawal), cognitive impairment, and poor insight, that severely impair patients’ everyday life.1,2 Insight is commonly interpreted as the patients’ ability to understand their own illness, but it is much more. It can also be defined as understanding how much the illness affects personal,3 occupational and social functioning, as well as managing the illness itself. The word ‘insight’ refers to a complex concept that should not be considered as an isolated symptom that is present or absent in a binary way. Conversely, it may be more appropriate to refer to insight as a continuum of feeling, influenced by several internal and external stimuli.3 Poor illness insight has been linked to low treatment adherence, more severe clinical outcomes, and severe cognitive and social cognition deficits, and functional performance.4–7 Therefore, improving and understanding insight physiopathology may be a milestone in diagnosis and treatment management for patients affected by schizophrenia. A patient's insight into his own illness in schizophrenia is a phenomenon at the clinical level that includes several dimensions, such as acknowledging the illness and of the symptoms, symptom attributions, beliefs about the need for treatment, and awareness of the consequence of illness and treatment.8,9 Phenomenologically, the lack of insight is one of the most prevalent symptoms of schizophrenia.10 The importance of understanding impaired insight in schizophrenia stems from poor treatment adherence,11 and its association with low cognitive and social functioning,12 high relapse rates, involuntary hospitalization,13 and overuse of emergency services. Furthermore, poor insight has been associated with increased suicide risk.14 One of the main hypotheses attributed a lack of insight to a defense mechanism, which may help patients adapt to their symptoms.15 Another clinical hypothesis focused on the independence insight from the underlying positive and negative symptoms.8 More recent frameworks suggested that the lack of insight could be a manifestation of the illness itself with explicit neurobiological correlates.16 Within this realm, neuroimaging studies indicated diverse brain alterations in patients with versus without impaired insight, suggesting specific neurobiological patterns underpinning lack of insight.17 Nevertheless, findings from magnetic resonance imaging (MRI) studies bear inconsistencies.18–20 The current neurobiological basis of understanding insight is based on the anosognosia model, suggesting the implication of several distributed cortical correlates of insight; related alterations have been reported in dorsolateral prefrontal, orbitofrontal, anterior cingulate, and parietal cortex.21 Conversely, methodological evaluation of insight has improved, and several scales of assessment have been developed. For a brief time, the Scale Unawareness of Mental Disorders (SUMD)22 was the most popular instrument, followed closely by the Scale Assessment of Insight-Expended (SAI-E)23 and the Birchwood Insight Scale (BIS).24 In addition, some studies assessed insight using a single item of the well-established Positive and Negative Symptom Scale (PANSS lack of Insight and Judgement item (PANSS G12)).25–28

With one exception,29 studies have assessed brain imaging correlates of impaired insight in patients with chronic schizophrenia.

Moreover, a previous work investigated the relationship between insight in first episode psychosis (FEP) and the executive functions deficit related to poor insight.30 Tordesillas-Gutierrez et al.29 observed smaller grey matter volumes in the right occipital lobe in first-episode patients (FEP) with poor insight compared to FEP with good insight. These alterations in the right hemisphere aligned with the right hemisphere dysfunction, which is suggested by the anosognosia model.31 The rest of the studies have mainly included patients with chronic schizophrenia. The long duration of the illness introduces a possible bias due to multiple confounders, such as long-term use of antipsychotic drugs, extended periods of substance use, and psychiatric comorbidity for these findings.32 Therefore, studies of FEP patients are of special interest for the understanding of the causes and the clinical impact of lack of insight.

Considering the heterogeneity for methodological approaches including insight scales, the patient samples and MRI techniques, the aim of this systematic review was meta-analyze grey matter volumetric data for the lack of insight in non-affective psychosis.

Methods

We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines for the reporting of this systematic review.33 The search strategy is available in the protocol registered with PROSPERO (registration number CRD42020148216).

Search strategy

Two authors (PSM and DTG) independently searched PubMed and OVID databases for research published until March 2020. Reference lists from included articles and past reviews were searched for additional studies, and eight references from these articles were added for later evaluation.

Article screening

Two researchers (PSM and DTG) independently screened the titles and abstracts of the initially identified articles and subsequently read the articles that met the eligibility criteria. In case of disagreement, a consensus was reached after discussion or the participation of a third reviewer (ESS).

Inclusion and exclusion criteria

For inclusion, we considered all the original published articles in English that investigated the brain grey matter volume correlates of impaired insight in schizophrenia, schizophreniform disorder, brief psychotic episode and other non-affective psychosis using MRI whole-brain voxel-based morphometry (VBM). The diagnosis must be verified by structured clinical interviews. We excluded non-original papers, such as review papers, abstracts, meeting letters, letters to editors without original scientific content, and commentaries, as well as case reports and non-peer-reviewed articles. Articles that only explore cognitive insight were excluded. Furthermore, studies that used functional or spectroscopy magnetic resonance and theoretical models were excluded. Additional exclusion criteria for the meta-analysis were: (1) peak coordinates were not reported, or t-maps were not available; (2) studies restricting the analysis to a priori small volume corrections; (3) studies reporting findings from multiple ROIs instead of the whole brain.

Data collection and extraction

Extracted data included author, year of publication of the study, number of subjects (patients and controls), studied population, age of the patients, insight symptom scale, insight dimension measured, MRI data protocol, statistical design, and key findings (Table 1). Authors were contacted in case of missing data.

Table 1.

Summary of characteristics of included studies.

Author, year  Patients/controls  Sample  Age patientsMean (SD)  Neuroimaging technique  ISS  MRI data protocol  Statistical threshold  Key findings 
Flashman et al., 2001  30/13  Chronic schizophrenia/healthy  AP: 36.4 (14.9)/UP: 33.9 (9.9)  sMRI  SUMD (1)Awareness of illness and symptoms  1.5TeslaBRAINS  p<0.05Corrected  No differences between aware and unaware patients after controlling for intracranial volumes, bilateral frontal, temporal, and parietal lobe tissue volumes. 
Flashman et al., 2000  15  Chronic schizophrenia  31.9 (11)  sMRI  SUMD (1)Awareness of current episode symptoms  1.5TeslaROI frontal lobe  p<0.01Corrected  Negative correlation between grey matter volumes in bilateral middle frontal gyri, L ACC and unawareness and misattribution of illness. 
Shad et al., 2006  14/21  FEP/healthy  16.23 (2.49)  sMRI  SUMD (2)Average total scores on awareness and attribution  1.5TeslaBRAINS  p<0.05Corrected  Negative correlations between awareness and R DLPFC as well as attribution and R medial OFC. No correlations between awareness/attribution and L DLFPC and L medial OFC, R or L lateral OFC volumes. 
Bassit et al., 2007  50/30  Chronic Schizophrenia/healthy  31.7 (7.1)  sMRI  SUMD (1)Sum of awareness and attribution of symptoms  1.5TeslaSPM2  p<0.05Corrected  No correlation between unawareness and misattribution of illness and grey or white matter volumes 
Bergé et al., 2011  21/20  FEP/healthy  24.81 (4.3)  sMRI  SUMD (1)Three initial global items  1.5TeslaSPM 5  p<0.001Uncorrected  Negative correlation between global items of SUMD scores and grey mater volumes in cerebellum bilaterally, R inferior temporal gyrus, R and L medial superior frontal gyrus, and R inferior frontal opercular gyrus. 
Buchy et al., 2009  54  FEP  23.4 (3.7)  sMRI  SUMD (2)Item 1, awareness of mental disorder  1.5Tesla  p<0.05Corrected  No correlations were detected between unawareness and misattribution of illness and hippocampus volume in R or L hemisphere. 
Buchy et al., 2011  79  FEP  23.3 (3.7)  sMRI  SUMD (2)Awareness of illness and composite awareness of treatment need/awareness of treatment efficacy scores  1.5TeslaCIVET: Cortical thickness  p<0.05Corrected  Negative correlations between awareness of illness and cortical thickness in the L DLPFC (middle frontal gyrus), L IFG, L ITG, L & R precentral gyrus and R IOG. For awareness of treatment need/efficacy negative correlations with cortical thickness in L DLPFC, L medial frontal gyrus, L precuneus, L paracentral lobule, L SMG, L superior, middle and inferior temporal gyri, L parahippocampal gyrus, the L MOG, the R IFG, R precuneus, R parietal & paracentral lobules, R supramarginal gyrus, R superior temporal gyrus, R parahippocampal gyrus, R fusiform & lingual gyri. 
Buchy et al., 2012  52  FEP  23.2 (3.8)  sMRI  SUMD (2)Attribution scores aggregated  1.5TeslaCIVET: Cortical thickness  (p<0.05)Corrected  Negative correlations between hallucination misattribution and L frontal, L inferior temporal and L middle occipital gyri, L precental gyrus, L cingulate gyrus and L parahippocampal gyrus. Positive correlations between hallucination misattribution and R superior, inferior and medial temporal, R inferior parietal lobule, R cingulate gyrus and R parahippocampal gyrus. Negative correlations between delusion misattribution and L frontal gyri. Positive correlations between delusion misattribution in L & R frontal, parietal, temporal and occipital gyri, L & R cingulate gyrus, L uncus, R cuneus. Negative correlations between flat affect misattribution and L frontal gyri, L pre- and postcentral gyrus, L inferior temporal gyrus, L middle occipitalis gyrus, L precuneus, L parahippocampal gyrus. Positive correlations between flat affect attribution and R frontal gyrus, R cuneus. Negative correlations between asociality misattribution and L frontal gyri, L inferior parietal lobule, L parahippocampal gyrus and R precentral gyrus. Positive correlations between asociality misattribution and R ACC and R superior temporal gyrus. 
Raij et al., 2012  21/16  Chronic schizophrenia/healthy  24.4  sMRI/fMRI  SUMD (1)Clinical insight  3TeslaSPM 8  p<0.001Corrected  No structural patterns for insight. Negative correlation between insight and activation strengths in L posterior cingulate cortex and L medial prefrontal cortex and R frontopolar cortex. 
McFarland et al., 2013  32 FEP/30 chronic  FEP/chronic schizophrenia  27.8 (7.6)/35.1 (8.7)  sMRI  SUMD (1)Awareness and symptom misattribution  1.5TeslaSnPM, ROI nucle caudate  p<0.05Corrected  In FEP negative correlation between symptom misattribution and grey matter excess in the R and L caudate, R thalamus, L insula, L putamen and L cerebellum. No correlation between awareness and grey matter in patients with chronic schizophrenia. 
Buchy et al., 2017  128  FEP  24.2  sMRI  SUMD (2)Sum of questions 1, 2a and 2b.  1.5TeslaCIVET: CT  p<0.05Uncorrected  No correlation between insight and cortical thickness at baseline to one year and two years follow up. 
Tordesillas et al., 2018*  108/77  FEP/healthy  26.92 (5.4)  sMRI  SUMD (2)Awareness of a mental disorder  1.5TeslaSPM5  p<0.05Corrected  Patients with poor versus good insight differed for grey matter volume in R occipital, cuneus and temporal cortical regions. 
Morgan et al., 2010  82/91  FEP/healthy  27.15 (7.58)  sMRI  SAI-ECombinedSAI-E scores  1.5TeslaAFNI  p<0.01Corrected  No correlations between symptom relabelling or total insight scores and volumetric measures for total, regional GM or lateral ventricular volume for the analysis within patients. Compared to patients with some relabelling ability (n=62), patients lacking relabelling ability (n=20) had reduced GM volumes in L insula, a cluster extending from R putamen to R STG & precentral gyrus, a cluster extending from L precentral gyrus to L STG, a bilateral cluster extending from the posterior cingulate gyrus to superior parietal lobe and a cluster extending from R precuneus to the R medial occipital gyrus. 
Gerretsen et al., 2015*  18  Chronic schizophrenia  41.7 (5.1)  sMRI/fMRI  SAI-EIllness awareness scores  1.5TeslaCIVET: CT; LONI: ROI  p<0.05Corrected  After correction for multiple comparisons no correlation between illness awareness and cortical thickness in L angular gyrus. Peak brain activity in the left TPO was positively associated with impaired illness awareness. 
Emami et al., 2016*  66/31  Chronic schizophrenia/healthy  34.94 (7.96)  sMRI  SAI-EItem-7  3TeslaCIVET: CT; LONI: ROI  p<0.05Corrected  No cortical thickness differences between the low- and high-insight patients in the frontal lobe region, or in the superior temporal gyrus on either hemisphere. 
Asmal et al., 2016  92/93  FEP/healthy  24.68 (6.75)  sMRI  BISsymptom attribution’ subscale score  3TeslaFreesurfer: CT frontal. ROI  p<0.01Corrected  Negative correlation between relabelling symptoms and cortical thickness in L and R rostral middle frontal, L and R par triangularis L ACC, R superior frontal. Association between poor symptom attribution and L rostral middle frontal region and L ACC. L medial OFC, bilateral superior frontal, L frontal pole, R rostral middle frontal, R lateral OFC and R superior frontal regions. R rostral middle frontal, L caudal anterior cingulated. 
Sapara et al., 2007  40/20  Chronic schizophrenia/healthy  13.45 (10.93)  sMRI  BIS SAI-EInsight into symptoms, illness, need for treatment and consequences.  1.5TeslaSPM 8  p<0.05Corrected  Positive correlation in patients with poor illness insight shown less grey matter volume than patients with good illness insight in the inferior frontal and precentral gyri, superior and middle temporal gyri, parahippocampus, cuneus and cerebellum of both cerebral hemispheres. 
Sapara et al., 2016*  28/20  Chronic schizophrenia/healthy  39 (10.51)  sMRI  BIS“Preserved insight” defined as a minimum score of 13 (out of 14) and “impaired insight” as a score of 8 or below.  1.5TeslaManual ROI  p<0.05Corrected  Positive correlation between BIS sub-scale of the level of insight into illness and the total prefrontal (IFG, OFG, SFG, MFG) grey matter volumes in both hemispheres. Patients with smaller total prefrontal grey matter volumes were less aware of having a mental illness. SAI-E reflected these relationships most strongly. 
Cooke et al., 2008*  52/30  Chronic schizophrenia/healthy  38.35 (9.89)  sMRI  BIS SAI-ECombined: four factors of insight, awareness of and attribution to Illness, recognition of the need for medication, awareness of problems and symptom re-labelling  1.5TeslaSPM2  p<0.001Uncorrected  Positive correlation in patients with low score on Awareness of and Attribution to Illness shown reduce grey matter volume in L STG and MTG as well as R ITG. In Awareness of Problems there was an association between lower score and reduce grey matter volume in the L precuneus. Symptom Re-labelling shown that there was an association between low score and reduce grey matter volume in the R STG. 
Ha et al., 2004*  35/35  Chronic schizophrenia/healthy  27.8 (6.2)  sMRI  PANSSG12  1.5TeslaSPM 99  p<0.001 Uncorrected  Positive correlation in patients with higher score on lack of judgement and insight (G12) from the general psychopathology scale demonstrated further grey matter volume reductions in L and R cingulate gyrus and inferior temporal regions including the lateral fusiform gyri. 
Gerretsen et al., 2013  52  Chronic schizophrenia  41.5 (14.5)  sMRI  PANSSG12  1.5TeslaSPM8  p<0.001Uncorrected  Positive correlation between patients with higher score on lack of judgement and illness (G12) and reduce R grey matter volumes in the anteroinferior temporal lobe, OFC, and MPO. Only anteroinferior temporal lobe survived p<0.05 corrected. DBM showed associations between lack of illness awareness and reduce R grey matter volumes in the DLPFC, angular gyrus/parietal lobe, and insula. 
Shad et al., 2006  35  FEP  25.36  sMRI  HDRS-Item 22  1.5TeslaMRI  p<0.05Corrected  Negative correlation between HDRS-item 22 scores and GM in R DLPFC, but not L DLPFC, L & R hippocampus. 
Palaniyappan et al., 2011  57  Chronic schizophrenia  26.10 (7.49)  sMRI  SSPISItem 20  3TeslaFreesurfer  p<0.05Corrected  Negative correlation found in R posterior insula area associated with the degree of insight. 

Abbreviations: AFNI: analysis of functional neuroimages; ACC: anterior cingulate cortex; AP: aware patients; BIS: Birchwood Insight Scale; BRAINS: Brain Research Analysis of Images Networks and Systems; CIVET: image processing pipeline for fully automated volumetric; corticometric and morphometric analysis of brain imaging data; CT: cortical thickness; DLPFC: dorso-lateral prefrontal cortex; DBM: deformation-based morphometry; DLPFC: dorso-lateral prefrontal cortex; FEP: first episode psychosis; GM: grey matter; HC: healthy controls; HDRS: Hamilton Depression Rating Scale; HPC: hippocampal area; IFG: inferior frontal gyrus; IOG: inferior occipital gyrus; ISS: insight symptom scale; ITG: inferior temporal gyrus; MFG: middle frontal gyrus; MOG: middle occipital gyrus; MPC: medial prefrontal cortex; MTG: middle temporal Gs; OFC: orbitofrontal cortex; ROI: region of interest; PANSS: Positive and Negative Syndrome Scale; SAI-E: Expanded Schedule of Assessment of Insight; SFG: superior frontal gyrus; SMG: supramarginal gyrus; sMRI: Structural Magnetic Resonance Imaging; SnPM: Statistical Non-Parametric Mapping; SPM: Statistical Parametric Mapping; SSPIS: Symptoms and Signs in Psychotic Illness Scale; STG: superior temporal gyrus; SUMD: Scale to Assess Unawareness of Mental Disorder; UP: unaware patients. (1) Amador et al. (1993); (2) Amador et al. (1994).

*

Studies included in the meta-analysis.

Assessment of the quality of the evidence in the studies

Following previous methodological approaches for the ABC quality assessment test of imaging studies,34 we based the study on two main criteria: the statistical power (i.e., sample size) and the multidimensional assessment of insight (i.e., the assessment of different aspects of insight). The rationale for the selection of the sample size as a quality criterion was previously discussed.34 The assessment of different aspects of insight is expected to provide a more sophisticated measure than a single item. The sample sizes were classified as follows: category 1: less than 15 participants per study group; category 2: 15–30 participants per study group and category 3: more than 30 participants per group.

The assessment of insight of studies was categorized as if it was (1) unidimensional (i.e., the inclusion of one single item of a scales in the analysis) and (2) multidimensional covering different aspects of insight (regardless of the number of the applied scales). Totaling the scores, a maximum score of 5 was considered to be quality A (good), while 4 was quality B (moderate), and 3 or below quality C (low).

Meta-analytic methods

To pool the VBM data, we used Seed-based d Mapping with Permutation of Subject Images (SDM-PSI).35,36 The main advantage of this method is that it directly tests whether there are correlations between VBM and insight, rather than conducting indirect tests such as whether peaks tend to converge in some regions more than in others.37 Additionally, it is unique in both allowing the powerful inclusion of original statistical maps instead of peak coordinates,38 and in allowing the combination of VBM and cortical thickness studies.39 First, we converted all coordinates to a common MNI space. Second, we created the maps of the lower and upper bounds of possible effect sizes for each study based on the level of statistical significance, the coordinates and effect size of the reported peaks, and the anisotropic covariance between adjacent voxels.40 Third, we imputed multiple effect size maps (and the corresponding variance maps) for each study,36 restricted to the FreeSurfer mask.39 Fourth, we combined the images of each dataset of imputed effect size maps using a standard random-effects meta-analysis. Fifth, we combined the meta-analytic maps resulting from the various imputations using Rubin's rules.41 Finally, we imputed the subject images for each study, and we assessed the statistical significance via a permutation test of the subject images.36 We considered statistically significant those voxels with threshold-free cluster enhancement (TFCE)42 familywise error rate (FWER) <0.05, and trend-level those voxel with uncorrected p<0.001 and cluster-extend of 10 voxels. We also assessed the between-study heterogeneity with the I2 statistic (<50% is considered absence of substantial heterogeneity) and conducted Egger tests to evaluate potential publication bias in the findings.

ResultsReview flow

The flowchart of the systematic review is shown in Fig. 1.

Figure 1.

PRISMA flow-chart.

(0.34MB).

Of the 418 articles selected based on the search criteria, we found 50 duplicated, which were then excluded. After reading the title and abstracts, 124 articles were selected as potentially relevant, and 244 studies were excluded because they did not identify a direct relationship between clinical insight, clinical assessment, and GMV. Of these 124 articles, 101 were excluded because they were functional magnetic resonance imagining (fMRI) studies (n=78), cognitive insight (n=16), spectroscopy studies (n=5), and theoretical models (n=2). Finally, 23 articles with a total of 697 FEP, 572 chronic patients and 569 healthy controls were included (Fig. 1). Twelve articles used the SUMD scale,19,29,43–52 three articles used the SAI-E scale,53–55 two articles used the BIS scale,56,57 two articles used BIS and SAI-E scales,58,59 two articles used the PANSS G12 scale,60,61 one article used Hamilton Depression Rating Scale (HDRS)62 and another article used Symptoms and Signs in Psychotic Illness scale (SSPIS).63

Correlations between assessment scales ratings and grey matter volumeRelationship between The Scale to Assess Unawareness of Mental Disorder (SUMD) and grey matter volume alterations

Of the 23 studies reviewed, 10 used the SUMD for the assessment of insight. The early work of Flashman et al.,43,44 assessed the brain imaging correlates of insight deficits in chronic patients using a region of interest approach (ROI).

In their first study in 2000, they investigated whether there were any differences in brain and intracranial volumes of frontal, temporal, and parietal lobe between patients with good and poor insight reporting no differences.44 In their second study, inverse correlations were found between the level of unawareness and grey matter volume in bilateral middle frontal gyrus, right gyrus rectus, and left anterior cingulate gyrus. Furthermore, smaller volumes of both hemispheres’ superior frontal gyrus were associated with higher misattribution scores.43

In an FEP cohort Shad et al.,45 awareness of symptoms was inversely associated with dorso-lateral prefrontal cortex (DLPFC) volume. Moreover, structural alteration in orbitofrontal cortex (OFC) was correlated with the average score on attribution symptoms. Nevertheless, the same study found no GMV differences between control and patients.

Likewise, Bassitt et al.,46 using voxel brain morphometry found no differences between 50 chronic patients and 30 healthy subjects. Conversely, Bergé et al.,47 in FEP patients found a significant inverse correlation between insight impairment and GMV volume in several brain areas including the cerebellum, right inferior temporal gyrus, superior frontal gyrus and right inferior frontal gyrus in 21 drug naïve FEP patients.

Between 2010 and 2017, Buchy and colleagues published several papers on different brain areas in the context of insight in a FEP sample. In 2010, they explored the hippocampus volume in association with verbal memory and cognitive insight without reporting any association.48 A later study reported that poor awareness of illness was associated with regional thinning in left middle frontal and inferior temporal gyrus; on the contrary, unawareness of treatment need and efficacy was associated with cortical thinning in precuneus, left medial frontal gyrus, and temporal gyri.49 Moreover, this group identified an association between thickness in OFC in delusion misattribution, which was associated with thickness in FEP.50 Finally, a longitudinal study on cognitive and neuroimaging predictors of clinical insight reported no interaction in cortical thickness and baseline, one- or two-year follow-up assessments of insight in FEP.

The study by Raij et al.51 in patients with chronic psychosis, found no correlation between brain volumes and insight impairment. This was similar to the study of McFarland et al.,52 which also did not find any significant associations between GMV in any area of the whole brain and the measures of insight in FEP patients. Interestingly, the same article showed a significant association between the insight deficits and symptom misattribution with grey matter thickness in bilateral caudate, right thalamus, left insula, putamen, and cerebellum in FEP patients.

Relationship between Schedule of Assessment of Insight-Expanded (SAI-E) and grey matter volume

Three volumetric studies included the SAI-E for the assessment of insight. One sample investigated a FEP sample53; patients without symptom relabeling ability differed with regard to GMV in the posterior cingulate gyrus and right precuneus compared to patients with relabeling ability. Conversely, Gerretsen et al.,54 comparing aware versus unaware chronic patients reported cortical thickness in left angular gyrus for the illness denial. In chronic psychosis, Emami et al.,55 evidence indicates thinner parahippocampal volume and superior temporal gyrus showed poor insight in patients compared to healthy subjects.

Relationship between Positive and Negative Syndrome Scale (PANSS) and grey matter volume

The study by Ha et al.,60 found lower grey matter volumes in the left posterior and the right anterior cingulate gyrus using PANSS G1264 in chronic paranoid patients.

Relationship between Birchwood Insight Scale (BIS) and grey matter volume

The larger sample study by Asmal et al.,56 pointed to a correlation between symptom attribution measured with BIS and frontal cortical thickness. Similarly, the study by Sapara et al.,57 compared stable schizophrenia patients with good or poor insight with healthy controls. The group with good insight showed larger GMV in inferior frontal and precentral gyri, superior and middle temporal gyri, parahippocampus, cuneus, and bilateral cerebellum compared to patients with poor insight showed grey matter reductions compared to healthy controls and awareness patients in the above-mentioned brain areas.

Relationship between BIS and SAI-E scales and grey matter volume

There were two studies in which BIS and SAI-E were both administered. First, Sapara et al.58 conducted a study with a group of twenty-eight stable chronic patients, examining whether there were differences in prefrontal GMV related to poor insight; smaller prefrontal GMV was associated with a lower level of insight only in males. The second study, run by Cooke et al.59 found lower grey matter volumes in the temporal and parietal regions that have been implicated in self-monitoring, working memory and access to internal mental states are associated with poor insight in a large chronic sample.

Assessment of quality of included studies

Eleven studies were classified as high quality (A: sum score 5), nine studies as moderate quality (B: sum score 4) and three studies of low quality (C: sum score 2 or 3), as illustrated in Table 2. Regarding sample size, 15 studies had adequate statistical power, five studies moderate and three studies poor statistical power. In terms of insight assessment, four trials used values of single items for insight evaluation, whereas 19 studies used scales that covered different dimensions of insight.

Table 2.

Quality assessment of included studies according to ABC scale.

Study  Sample size  Insight dimension  Quality level 
Asmal et al. (2016) 
Bassit et al. (2007) 
Bergé et al. (2011) 
Buchy et al. (2010) 
Buchy et al. (2011) 
Buchy et al. (2012) 
Buchy et al. (2017) 
Cooke et al. (2008) 
Emami et al. (2016) 
Flashman et al. (2000) 
Flashman et al. (2001) 
Gerretsen et al. (2013) 
Gerretsen et al. (2015) 
Ha et al. (2004) 
McFarland et al. (2013) 
Morgan et al. (2010) 
Palaniyappan et al. (2011) 
Raij et al. (2012) 
Sapara et al. (2016) 
Sapara et al. (2007) 
Shad et al. (2006) 
Shad et al. (2007) 
Tordesillas et al. (2018) 

Notes. Sample size: 1 <15 participants/group, 2=15–30 participants/group, 3 >30 participants per group. Insight dimension measured: 1=unidimensional, 2=multidimensional. Quality level: A (sum score 5)=good, B (sum score 4)=medium. C=(sum score 3 or 2)=low.

We could include 11 studies to the meta-analysis, comprising one original statistical map,65 eight studies reporting several peaks, and three studies with no findings. The studies comprised 710 patients, and the original statistical map 264 patients. The meta-analysis showed a positive correlation between grey matter volume/cortical thickness and insight in right insula, Brodmann area 48 (peak at MNI=[48,14, −2], Z=3.8, uncorrected p=0.00006, Fig. 2). This result showed neither substantial heterogeneity (I2=2.4%) nor hints of publication bias (Egger's test p=0.79), and it was not statistically significant after FWER correction for multiple voxel testing.

Figure 2.

Positive correlation between grey matter volume/cortical thickness and insight in right insula.

(0.14MB).
Discussion

To the best of our knowledge, this report is the largest review concerning studies on insight and GMV findings in non-affective psychosis using magnetic resonance imaging (MRI).

The meta-analysis showed an uncorrected positive correlation between grey matter volume/cortical thickness and insight in the right insula. As a major component of the “limbic integration cortex,” the insula is widely interconnected with cortical and limbic areas.66

The insula is a key component of a general salience network,67 prompting us to believe that insular dysfunction and alterations between network interactions might be characteristic of schizophrenia. The decrease in grey matter volume has been associated with neurological soft signs in ultra-high risk subjects.68 As such, because the insula plays a role in self awareness,69 it could also be linked to a patient's ability to recognize that his or her symptoms stem from the illness.

In the systematic review of 23 studies, 15 revealed that there are mainly two brain areas affected: The frontal and temporal lobes. That said, the studies also indicated that reductions were reported in midline, precuneus, insula, and occipital cortical volumes. Each brain area is discussed separately below.

Frontal lobe

Our systematic review highlights the consistently reported involvement of altered prefrontal and frontal structures in lack of insight in patients with psychosis.43,47,49,50,58,62 Several results emerge from these studies, which have used cortical thickness techniques to observe regional thinning in left middle frontal associated with poor insight.49,54–57 This finding might support the conclusion that smaller frontal volumes characterize patients with poor insight.43,45,47,57,62,70

Furthermore, a meta-analysis showed that reduced DLPFC is altered and associated with positive and negative symptoms; Mintz et al.,28 claimed that the lack of insight is part of psychopathological conditions. In this framework, reduced volumes of OFC provided evidence that decreased prefrontal volumes lead to lower levels of clinical insight.58,71 However, this is inconsistent with the notion that increases in GMV in drug naïve FEP involved the prefrontal cortex, including OFC.72 In line with these findings, the alteration of OFC related to poor insight might be associated with the disability and loss of attribution because of the illness itself and its related psychotic complications. The involvement of specific patterns in dorsolateral prefrontal cortex and orbitofrontal cortex related to clinical insight may account for the implication of their associated basic cognitive process, such as working memory and cognitive control decision-making, respectively.18,45

Temporal lobe

A trend of differences in temporal cortex volumes associated with clearly poor insight in FEP and chronic patients.43,59–61 Indeed, volume reduction in superior temporal cortex is compatible with empirical studies of functional deficits and thought disorder in psychosis patients.73 However, it is unclear if hippocampus alterations in FEP and chronic patients are associated with other altered cognitive functions affecting the lack of insight. One possible explanation for these alterations in light of the temporal lobe implication can be that it plays a specific role in awareness and relabeling factors, which might affect the ability of insight and attribution.60,61

Parietal and occipital lobes

Authors found that awareness of problems, poor symptom relabeling, and awareness of treatment effects were associated with cortical thinning in left precuneus.49,53,59

Also, Cooke et al.59 found that awareness of symptoms was related to a decrease in GMV in lateral parietal gyri, and Gerretsen et al.54 claimed that illness denial was correlated with cortical thinning of the left angular gyrus and illness awareness to parietal lobe asymmetry. From these studies, the ones that show reduction in the precuneus are also those with the larger sample sizes or the ones conducted in FEP patients.

From the first neuroimaging studies, the parietal lobe has been associated with psychotic experiences.74 More recent studies identified disturbed parieto-occipital functional connectivity as related to schizophrenia.75,76

Precuneus showed alterations in both unaffected siblings and in patients with schizophrenia when related to healthy controls,77 and a recently published article indicated abnormal regional homogeneity and correlation with clinical symptoms in drug naïve first episode patients.78

The occipital lobe showed poor insight in four studies that used non-driven whole brain analysis,29,53,57,59 both in chronic and FEP subjects. Reduction in the inferior and middle occipital gyrus has been linked to the age of the patient at the onset and diagnosis.29,79 Both Morgan et al. and Tordesillas et al.29,53 found reductions in the right cuneus in large groups of FEP subjects.

Other brain regions

Alterations in midline cortical volumes, such as anterior cingulate regions, with bilateral reduction, have been associated with poor insight.60 Previously, neurobiological abnormalities in cingulate cortex have been linked to phenomenology of psychiatric illness,80 and related to altered self-monitoring.81 This fact might explain the inability to assess mental experiences. In addition, inverse correlations between unawareness and anterior cingulate gyrus volume were described.43 Our systematic review further showed two studies throughout region of interest approaches found thinner bilateral insula cortex in patients with poor insight,52,55 and also meanly in right posterior insula.63 These results may stem from the established function of the insula in its emotional and cognitive modulation.82 Importantly, evidence from neuroanatomical studies suggests that certain insula might address misattributed internal information to an external source.83 In this sense, Crespo-Facorro et al.,84 reported that reduction in insular GMV and cortical surface size are associated with the severity of psychotic symptoms in schizophrenia.

Reviewing the studies that included 50 or more patients closely, we found that those were the studies with the most widespread findings, including frontal, temporal, and occipital areas. That could mean that large, homogeneous samples are needed to show subtle differences in patients with insight deficits. Nonetheless, the scales showed high levels of correlation,85 it might mean that they are measuring different dimensions of insight. These results suggest that merging different techniques is needed, acknowledging that cortical thickness might be one of the most sensitive aspects to measure cortical alteration rather than volumetric studies.86,87

Integration of structural correlates of disturbances on insight

This systematic review showed that disturbances on insight dimensions in non-affective psychosis patients were significantly related to a great variety of MRI brain structural abnormalities. Two main domains of reductions in grey matter were focused on cortical (frontal, temporal, parietal and occipital) and midline structures (anterior cingulate, precuneus and insula regions) accounted for most associations. 17 out of 23 studies reported significant reductions, six showed non-significant associations and only one study found significant increase of grey matter abnormalities in areas or midline structures (Table 1).

Thus, no total concordance among studies was found even though the associations between insight dimensions and cortical areas and midline structures were replicated in more than 2 studies. Studies examining laterality of abnormalities reported predominantly left-side abnormalities (7 left-side and 2 right-side abnormalities).

Differences due to the use of insight scale

Some of the heterogeneity in the findings can be attributed to the heterogeneity of the scales used to assess insight, despite the insight scales used were highly intercorrelated.88 In some studies, researchers chose to use specific parts of scales. If we take SUMD since it is the most used scale, we observed that six studies used the long version versus five studies that used the short version. This is relevant since both versions differ in contents and interpretation.89 Furthermore, although awareness of mental illness was a common variable to measure insight, a wide number of scores had been used. As Dumas et al.,89 express in their review “The use of modified versions of the SUMD (…) may affect psychometric properties such as validity” and may explain the inconsistencies of findings between studies using the SUMD scales. Specifically, five studies using this scale did report significant grey matter reductions associated with disturbances on insight dimensions, while six did not.

Structural abnormalities in grey matter may pave the way to functional or anatomically interregional disconnections in non-affective psychosis.90 Since brain structural abnormalities showed a great overlap with abnormalities reported in functional studies in non-affective psychosis, such as fMRI and diffusion tensor imaging (DTI) studies.91

Moreover, a network comprising frontal, temporal, thalamic and striatal regions are among the most frequently reported structural abnormalities in non-affective psychosis90 that are highly interconnected with grey matter of midline and subcortical structures.92,93

These areas are main hubs of large-scale brain networks serving numerous complex processes,94 including clinical insight. Moreover, the involvement of widespread structural brain abnormalities may account for the complexity of different clinical domains of non-affective psychosis and regarding insight domains.95

The correlates of insight in non-affective psychosis extend beyond the imaging findings reviewed here. For example, changes of the HPA axis (hypothalamus–pituitary–adrenal) might be present in patients with first episode psychotic disorders.96 There is also a study focusing on increased cortisol levels that were positively associated with poor insight in women with the first psychotic episodes.97 At the cellular level, impaired insight is related to decreased oligodendrocyte clusters in parietal brain regions98 and associated with genetic basis for insight impairments in schizophrenia Xavier et al.99 provided preliminary molecular evidence from both polygenic scores and specific candidate regions linking schizophrenia genetic liability to poor insight.

Although our findings summarize the relationships among clinical insight and structural abnormalities in non-affective psychotic patients, the study has some limitations, which to an extent derive from the limitations of the included studies. First, there is no consensus regarding the brain areas related to poor insight in non-affective psychosis, as there are many articles with no significant results. Several of these articles had limited statistical power and findings need to be considered with caution. Issues related to the administration of different insight scales may also contribute to the discrepancies. Moreover, one should also consider the variety of neuroimaging techniques used. Furthermore, methodological options such as the use of a low field MRI scanner or relatively liberal statistical threshold need to be considered.

Among the strengths of this review is, to our knowledge, the large size of the study systematic effort to summarize the data on the associations between grey matter and insight in patients with non-affective psychosis both chronic and FEP.

Future perspectives

We suggest the assessment of different dimensions of insight using standardized scales without modification. In this scenario, results from different studies could be better meta-analyzable and dissect the neural structures involved in each insight dimension.

Conclusion

In conclusion, this article argues that alterations in frontal and temporal regions were more frequently replicated in the context of lacking insight. However, there are several candidate areas, apart from fronto-temporal pathways, that might play a role in illness insight in non-affective psychosis, such as cingulate, insula, precuneus, and occipital lobe. Further large-scales research following the improvement of semiautomatic techniques in longitudinal samples is required to promote knowledge on GMV decreases associated with insight.

Funding

This study was supported by grants from the Consellería de Educación (PROMETEO/2016/082) and Carlos III Health Institute (ISCiii PI17/00402) cofunded by The European Union through FEDER funds. Funding sources had no further role in study design, review, analysis or interpretation of the data.

Conflict of interests

The authors declare that they have no conflict of interest.

References
[1]
M.J. Owen, A. Sawa, P.B. Mortensen.
Schizophrenia.
Lancet (London, England), 388 (2016), pp. 86-97
[2]
J. Dam.
Insight in schizophrenia: a review.
Nord J Psychiatry, 60 (2006), pp. 114-120
[3]
I.S. Markova, G.E. Berrios.
The meaning of insight in clinical psychiatry.
Br J Psychiatry, 160 (1992), pp. 850-860
[4]
Siu CO, Harvey PD, Agid O, Waye M, Brambilla C, Choi WK, et al. Insight and subjective measures of quality of life in chronic schizophrenia. Schizophr Res Cogn. 2015;2:127-32, https://doi.org/10.1016/j.scog.2015.05.002
[5]
Parellada M, Boada L, Fraguas D, Reig S, Castro-Fornieles, J, Moreno D, et al. Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: a 2-year longitudinal study. Schizophr Bull. 2011;37:38-51, https://doi.org/10.1093/schbul/sbq109
[6]
M.M. Kurtz, A. Tolman.
Neurocognition, insight into illness and subjective quality-of-life in schizophrenia: what is their relationship?.
Schizophr Res, 127 (2011), pp. 157-162
[7]
Reddy LF, Horan WP, Barch DM, Buchanan R, Dunayevich E, Gold J, et al. Effort-based decision making paradigms for clinical trials in schizophrenia: Part 1-- Psychometric characteristics of 5 paradigms. Schizophr Bull. 2015;41:1045-54, https://doi.org/10.1093/schbul/sbv089
[8]
M.J. Cuesta, V. Perlta.
Lack of insight in schizophrenia.
[9]
X.F. Amador, J.M. Gorman.
Psychopathologic domains and insight in schizophrenia.
Psychiatr Clin North Am, 21 (1998), pp. 27-42
[10]
X.F. Amador, A.S. David.
Insight and psychosis: awareness of illness in schizophrenia and related disorders.
[11]
J.P. McEvoy, M. Hartman, D. Gottlieb, S. Godwin, L.J. Apperson, W. Wilson.
Common sense, insight, and neuropsychological test performance in schizophrenia patients.
[12]
Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark SC, et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry. 1994, https://doi.org/10.1001/archpsyc.1994.03950100074007
[13]
Kelly BD, Clarke M, Browne S, Tigue MC, Kamali M, Gervin, M, et al. Clinical predictors of admission status in first episode schizophrenia. Eur Psychiatry. 2004;19:67-71, https://doi.org/10.1016/j.eurpsy.2003.07.009
[14]
Ayesa-Arriola R, Teran JMP, Morinigo JD, Canal Rivero M, Setien-Suero E, Al-Halabi S, et al. The dynamic relationship between insight and suicidal behavior in first episode psychosis patients over 3-year follow-up. Eur Neuropsychopharmacol. 2018:1-12, https://doi.org/10.1016/j.euroneuro.2018.05.005
[15]
W. Mayer-Gross.
Über Die Stellungnahme Zur Abgelaufenen Akuten Psychose.
Eine Studie Über Verständliche Zusammenhänge in Der Schizophrenie, 60 (1920),
[16]
American Psychiatric Association.
Diagnostic and statistical manual of mental disorders.
4th ed., American Psychiatric Association, (2000), http://dx.doi.org/10.1176/appi.books.9780890423349
[17]
Wexler BE, Zhu H, Bell MD, Nicholls S, Fullbright RK, Gore JC, et al. Neuropsychological near normality and brain structure abnormality in schizophrenia. Am J Psychiatry. 2009, https://doi.org/10.1176/appi.ajp.2008.08020258
[18]
A. Aleman, N. Agrawal, K.D. Morgan, A.S. David.
Insight in psychosis and neuropsychological function: meta-analysis.
[19]
L. Buchy, C. Makowski, A. Malla, R. Joober, M. Lepage.
Longitudinal trajectory of clinical insight and covariation with cortical thickness in first-episode psychosis.
J Psychiatr Res, 86 (2017), pp. 46-54
[20]
S.H. Mutsatsa, E.M. Joyce, S.B. Hutton, T.R.E. Barnes.
Relationship between insight, cognitive function, social function and symptomatology in schizophrenia: the West London first episode study.
Eur Arch Psychiatry Clin Neurosci, (2006),
[21]
M.U. Shad, M.S. Keshavan, C.A. Tamminga, C. Munro Cullum, A. David.
Neurobiological underpinnings of insight deficits in schizophrenia.
Int Rev Psychiatry, 19 (2007), pp. 437-446
[22]
X.F. Amador, D.H. Strauss, S.A. Yale, M.M. Flaum, J. Endicott, J.M. Gorman.
Assessment of insight in psychosis.
[23]
A. David, A. Buchanan, A. Reed, O. Almeida.
The assessment of insight in psychosis.
Br J Psychiatry, 161 (1992), pp. 599-602
[24]
M. Birchwood, J. Smith, V. Drury, J. Healy, F. Macmillan, M. Slade.
A self-report Insight Scale for psychosis: reliability, validity and sensitivity to change.
[25]
A. David, J. van Os, P. Jones, I. Harvey, A. Foerster, T. Fahy.
Insight psychotic illness. Cross-sectional longitudinal associations.
[26]
M.S. Keshavan, J. Rabinowitz, G. Desmedt, P.D. Harvey, N. Schooler.
Correlates of insight in first episode psychosis.
[27]
M. Lepage, L. Buchy, M. Bodnar, M.C. Bertrand, R. Joober, A. Malla.
Cognitive insight and verbal memory in first episode of psychosis.
[28]
A.R. Mintz, K.S. Dobson, D.M. Romney.
Insight in schizophrenia: a meta-analysis.
[29]
D. Tordesillas-Gutierrez, R. Ayesa-Arriola, M. Delgado-Alvarado, et al.
The right occipital lobe and poor insight in first-episode psychosis.
[30]
Ayesa-Arriola R, Rodriguez-Sanchez JM, Morelli C, Pelayo-Terán JM, Pérez-Iglésias R, Mata I, et al. Insight dimensions in first-episode psychosis patients: clinical, cognitive, pre-morbid and socio-demographic correlates. Early Interv Psychiatry. 2011;5:140-9, https://doi.org/10.1111/j.1751-7893.2010.00249.x
[31]
P. Vuilleumier.
Anosognosia: the neurology of beliefs and uncertainties.
[32]
Friedman JI, Tang C, Carpenter D, Buchsbaum M, Schmeidler J, Flanagan L, et al. Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am J Psychiatry. 2008, https://doi.org/10.1176/appi.ajp.2008.07101640
[33]
D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
Int J Surg, 8 (2010), pp. 336-341
[34]
M. Cavelti, T. Kircher, A. Nagels, W. Strik, P. Homan.
Is formal thought disorder in schizophrenia related to structural and functional aberrations in the language network? A systematic review of neuroimaging findings.
Schizophr Res, 199 (2018), pp. 2-16
[35]
Albajes-Eizagirre A, Solanes A, Fullana MA, Ioannidis JPA, Fusar-Poli P, Torrent C, et al. Meta-analysis of voxel-based neuroimaging studies using seed-based d mapping with permutation of subject images (SDM-PSI). J Vis Exp. 2019;2019, https://doi.org/10.3791/59841
[36]
A. Albajes-Eizagirre, A. Solanes, E. Vieta, J. Radua.
Voxel-based meta-analysis via permutation of subject images (PSI): theory and implementation for SDM.
Neuroimage, 186 (2019), pp. 174-184
[37]
A. Albajes-Eizagirre, J. Radua.
What do results from coordinate-based meta-analyses tell us?.
Neuroimage, 176 (2018), pp. 550-553
[38]
Radua J, Mataix-Cols D, Phillips ML, El-Hage W, Kronhaus DM, Cardoner N, et al. A new meta-analytic method for neuroimaging studies that combines reported peak coordinates and statistical parametric maps. Eur Psychiatry. 2012;8:605-11, https://doi.org/10.1016/j.eurpsy.2011.04.001
[39]
Li Q, Zhao Y, Chen Z, Long J, Dai J, Huang X, et al. Meta-analysis of cortical thickness abnormalities in medication-free patients with major depressive disorder. Neuropsychopharmacology. 2020;45:703-12, https://doi.org/10.1038/s41386-019-0563-9
[40]
J. Radua, K. Rubia, E.J. Canales-Rodríguez, E. Pomarol-Clotet, P. Fusar-Poli, D. Mataix-Cols.
Anisotropic kernels for coordinate-based meta-analyses of neuroimaging studies.
Front Psychiatry, 10 (2014), pp. 5-13
[41]
A. Albajes-Eizagirre, A. Solanes, J. Radua.
Meta-analysis of non-statistically significant unreported effects.
Stat Methods Med Res, 28 (2019), pp. 3741-3754
[42]
S.M. Smith, T.E. Nichols.
Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.
[43]
L.A. Flashman, T.W. McAllister, S.C. Johnson, J.H. Rick, R.L. Green, J.A. Saykin.
Specific frontal lobe subregions correlated with unawareness of illness in schizophrenia: a preliminary study.
J Neuropsychiatry Clin Neurosci, 13 (2001), pp. 255-257
[44]
L.A. Flashman, T.W. McAllister, N.C. Andreasen, A.J. Saykin.
Smaller brain size associated with unawareness of illness in patients with schizophrenia.
Am J Psychiatry, 157 (2000), pp. 1167-1169
[45]
M.U. Shad, S. Muddasani, M.S. Keshavan.
Prefrontal subregions and dimensions of insight in first-episode schizophrenia – a pilot study.
Psychiatry Res – Neuroimaging, 146 (2006), pp. 35-42
[46]
D.P. Bassitt, M.R.L. Neto, C.C. De Castro, G.F. Busatto.
Insight and regional brain volumes in schizophrenia.
Eur Arch Psychiatry Clin Neurosci, 257 (2007), pp. 58-62
[47]
D. Bergé, S. Carmona, M. Rovira, A. Bulbena, P. Salgado, O. Vilarroya.
Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects.
Acta Psychiatr Scand, 123 (2011), pp. 431-439
[48]
Buchy L, Czechowska Y, Chochol C, Malla A, Joober R, Pruessner J, et al. Toward a model of cognitive insight in first-episode psychosis: verbal memory and hippocampal structure. Schizophr Bull. 2010;36:1040-9, https://doi.org/10.1093/schbul/sbp015
[49]
Buchy L, Ad-Dab’bagh Y, Malla A, Lepage C, Bodnar M, Joober R, et al. Cortical thickness is associated with poor insight in first episode psychosis. J Psychiatr Res. 2011;45:781-7, https://doi.org/10.1016/j.jpsychires.2010.10.016
[50]
Buchy L, Ad-Dab’bagh Y, Lepage C, Malla A, Joober R, Evans A, et al. Symptom attribution in first episode psychosis: a cortical thickness study. Psychiatry Res - Neuroimaging. 2012;203:6-13, https://doi.org/10.1016/j.pscychresns.2011.09.009
[51]
T.T. Raij, T.J.J. Riekki, R. Hari.
Association of poor insight in schizophrenia with structure and function of cortical midline structures and frontopolar cortex.
Schizophr Res, 139 (2012), pp. 27-32
[52]
McFarland J, Cannon DM, Schmidt H, Ahmed M, Hehir S, Emsell L, et al. Association of grey matter volume deviation with insight impairment in first-episode affective and non-affective psychosis. Eur Arch Psychiatry Clin Neurosci. 2013;263:133-41, https://doi.org/10.1007/s00406-012-0333-8
[53]
Morgan KD, Dazzan P, Morgan C, Lappin J, Hutchinson G, Suckling J, et al. Insight, grey matter and cognitive function in firstonset psychosis. Br J Psychiatry. 2010;197:141-8, https://doi.org/10.1192/bjp.bp.109.070888
[54]
Gerretsen P, Menon M, Chakravarty MM, Lerch JP, Mamo DC, Remington G, et al. Illness denial in schizophrenia spectrum disorders: a function of left hemisphere dominance. Hum Brain Mapp. 2015;36:213-25, https://doi.org/10.1002/hbm.22624.
[55]
S. Emami, S. Guimond, M. Mallar Chakravarty, M. Lepage.
Cortical thickness and low insight into symptoms in enduring schizophrenia.
Schizophr Res, 170 (2016), pp. 66-72
[56]
L. Asmal, S. du Plessis, M. Vink, B. Chiliza, S. Kilian, R. Emsley.
Symptom attribution and frontal cortical thickness in first-episode schizophrenia.
Early Interv Psychiatry, (2016), pp. 1-8
[57]
A. Sapara, D.H. Ffytche, M.A. Cooke, S.C. Williams, V. Kumari.
Voxel-based magnetic resonance imaging investigation of poor and preserved clinical insight in people with schizophrenia.
World J Psychiatry, 6 (2016), pp. 311
[58]
Sapara A, Cooke M, Fannon D, Francis A, Buchanan RW, Anilkumar AP, et al. Prefrontal cortex and insight in schizophrenia: a volumetric MRI study. Schizophr Res. 2007;89:22-34, https://doi.org/10.1016/j.schres.2006.09.016
[59]
M.A. Cooke, D. Fannon, E. Kuipers, E. Peters, S.C. Williams, V. Kumari.
Neurological basis of poor insight in psychosis: a voxel-based MRI study.
Schizophr Res, 103 (2008), pp. 40-51
[60]
Ha TH, Youn T, Ha KS, Rho, KS, Lee JM, Kim IY, et al. Gray matter abnormalities in paranoid schizophrenia and their clinical correlations. Psychiatry Res - Neuroimaging. 2004;132:251-60, https://doi.org/10.1016/j.pscychresns.2004.05.001
[61]
Gerretsen P, Chakravarty MM, Mamo D, Menon M, Pollock B, Rajjii T, et al. Frontotemporoparietal asymmetry and lack of illness awareness in schizophrenia. Hum Brain Mapp. 2013;34:1035-43, https://doi.org/10.1002/hbm.21490
[62]
M.U. Shad, S. Muddasani, K. Prasad, J.A. Sweeney, M.S. Keshavan.
Insight and prefrontal cortex in first-episode Schizophrenia.
Neuroimage, 22 (2004), pp. 1315-1320
[63]
L. Palaniyappan, P. Mallikarjun, V. Joseph, P.F. Liddle.
Appreciating symptoms and deficits in schizophrenia: right posterior insula and poor insight.
Prog Neuro-Psychopharmacol Biol Psychiatry, 35 (2011), pp. 523-527
[64]
S.R. Kay, A. Fiszbein, L.A. Opler.
The positive and negative syndrome scale (PANSS) for schizophrenia.
[65]
D. Tordesillas-Gutierrez, N. Koutsouleris, R. Roiz-Santiañez, et al.
Grey matter volume differences in non-affective psychosis and the effects of age of onset on grey matter volumes: a voxelwise study.
[66]
M.-M. Mesulam, E.J. Mufson.
The insula of reil in man and monkey.
Springer, (1985), pp. 179-226 http://dx.doi.org/10.1007/978-1-4757-9619-3_5
[67]
L. Palaniyappan, P.F. Liddle.
Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction.
J Psychiatry Neurosci, 37 (2012), pp. 17-27
[68]
Kong L, Cui H, Zhang T, Huang J, Zhu Y, Tang Y, Herold CJ, et al. Neurological soft signs and grey matter abnormalities in individuals with ultra-high risk for psychosis. Psych J. 2019;8:252-60, https://doi.org/10.1002/pchj.258
[69]
A.D. Craig.
How do you feel – now? The anterior insula and human awareness.
Nat Rev Neurosci, 10 (2009), pp. 59-70
[70]
M. Orfei, F. Piras, E. Macci, C. Caltagirone, G. Spalletta.
The neuroanatomical correlates of cognitive insight in schizophrenia.
Soc Cogn Affect Neurosci, (2013),
[71]
W. Schultz, L. Tremblay, J.R. Hollerman.
Reward processing in primate orbitofrontal cortex and basal ganglia.
Cereb Cortex, 10 (2000), pp. 272-284
[72]
Ren W, Lui S, Deng W, Li F, Li M, Huang X, et al. Anatomical and functional brain abnormalities in drug-naive firstepisode schizophrenia. Am J Psychiatry. 2013, https://doi.org/10.1176/appi.ajp.2013.12091148
[73]
Shenton ME, Kikinis R, Jolesz FA, Pollak SD, Lemay M, Wible CG, et al. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. N Engl J Med. 1992, https://doi.org/10.1056/NEJM199208273270905
[74]
S.A. Spence, D.J. Brooks, S.R. Hirsch, P.F. Liddle, J. Meehan, P.M. Grasby.
A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control).
[75]
I. Henseler, P. Falkai, O. Gruber.
Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: relation to performance and clinical symptoms.
[76]
D. Mastrovito, C. Hanson, S.J. Hanson.
Differences in atypical resting-state effective connectivity distinguish autism from schizophrenia.
[77]
S. Guo, W. Zhao, H. Tao, Z. Liu, L. Palaniyappan.
The instability of functional connectivity in patients with schizophrenia and their siblings: a dynamic connectivity study.
Schizophr Res, 195 (2018), pp. 183-189
[78]
Zhao X, Yao J, Lv Y, Zhang X, Han CH, Chen L, et al. Abnormalities of regional homogeneity and its correlation with clinical symptoms in Naive patients with first-episode schizophrenia. Brain Imaging Behav. 2018:1-11, https://doi.org/10.1007/s11682-018-9882-4
[79]
Torres US, Duran FLS, Schaufelberger MS, Crippa JA, Louza MR, Sallet PC, et al. Patterns of regional gray matter loss at different stages of schizophrenia: a multisite, cross-sectional VBM study in first-episode and chronic illness. NeuroImage Clin. 2016, https://doi.org/10.1016/j.nicl.2016.06.002
[80]
F.M. Benes.
Neurobiological investigations in cingulate cortex of schizophrenic brain.
Schizophr Bull, 19 (1993), pp. 537-549
[81]
P.F. Liddle, K.J. Friston, C.D. Frith, S.R. Hirsch, T. Jones, R.S.J. Frackowiak.
Patterns of cerebral blood flow in schizophrenia.
[82]
P.G. Gasquoine.
Contributions of the insula to cognition and emotion.
Neuropsychol Rev, 24 (2014), pp. 77-87
[83]
K.P. Wylie, J.R. Tregellas.
The role of the insula in schizophrenia.
Schizophr Res, 3 (2010), pp. 93-104
[84]
B. Crespo-Facorro, J.J. Kim, N.C. Andreasen, D.S. O’leary, H.J. Bockholt, V. Magnotta.
Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients.
Schizophr Res, 46 (2000), pp. 35-43
[85]
J. Soriano-Barceló, A.S. David.
Insight assessment in psychosis and psychopathological correlates: validation of the Spanish version of the Schedule for Assessment of Insight – Expanded Version.
Eur J Psychiatry, (2016),
[86]
Narr KL, Bilder RM, Toga AW, Woods RP, Rex DE, Szeszko PR, et al. Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cereb Cortex. 2005, https://doi.org/10.1093/cercor/bhh172
[87]
Schultz CC, Koch K, Wagner G, Roebel M, Schachtzabel C, Gaser CH, et al. Reduced cortical thickness in first episode schizophrenia. Schizophr Res. 2010, https://doi.org/10.1016/j.schres.2009.11.001
[88]
M.J. Cuesta, V. Peralta, A. Zarzuela.
Reappraising insight in psychosis. Multi-scale longitudinal study.
Br J Psychiatry, 177 (2000), pp. 233-240
[89]
R. Dumas, K. Baumstarck, P. Michel, C. Lançon, P. Auquier, L. Boyer.
Systematic review reveals heterogeneity in the use of the scale to assess unawareness of mental disorder (SUMD).
Curr Psychiatry Rep, 15 (2013),
[90]
A. Fornito, M. Yücel, J. Patti, S.J. Wood, C. Pantelis.
Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies.
Schizophr Res, 108 (2009), pp. 104-113
[91]
B. Ćurčić-Blake, L. van der Meer, G.H.M. Pijnenborg, A.S. David, A. Aleman.
Insight and psychosis: functional and anatomical brain connectivity and self-reflection in Schizophrenia.
Hum Brain Mapp, 36 (2015), pp. 4859-4868
[92]
I.C. Wright, S. Rabe-Hesketh, P.W.R. Woodruff, A.S. David, R.M. Murray, E.T. Bullmore.
Meta-analysis of regional brain volumes in schizophrenia.
[93]
van Erp TGM, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016;21:547-53, https://doi.org/10.1038/mp.2015.63
[94]
M. Rubinov, E. Bullmore.
Schizophrenia and abnormal brain network hubs.
Dialogues Clin Neurosci, 15 (2013), pp. 339-349
[95]
B.G. Nelson, D.S. Bassett, J. Camchong, E.T. Bullmore, K.O. Lim.
Comparison of large-scale human brain functional and anatomical networks in schizophrenia.
[96]
Pruessner M, Bechard-Evans L, Pira S, Joober R, Collins DL, Pruessner JC, et al. Interplay of hippocampal volume and hypothalamus-pituitary-adrenal axis function as markers of stress vulnerability in men at ultra-high risk for psychosis. Psychol Med. 2017;47:471-83, https://doi.org/10.1017/S0033291716002658
[97]
Touskova TP, Bob P, Pec O, Mishara A, Vanickova Z, Raboch JR, et al. Insight and cortisol responses in women with first episode psychosis. Schizophr Res. 2018;201:428-9, https://doi.org/10.1016/j.schres.2018.06.002
[98]
V.M. Vostrikov, N.S. Kolomeets, N.A. Uranova.
Deficit of perineuronal oligodendrocytes in the inferior parietal lobule is associated with lack of insight in schizophrenia.
Eur J Psychiatry, 28 (2014), pp. 114-123
[99]
R.M. Xavier, A. Vorderstrasse, R.S.E. Keefe, J.R. Dungan.
Genetic correlates of insight in schizophrenia.
Schizophr Res, 195 (2018), pp. 290-297

Dual first authorship (PSM and GS contributed equally to this article).

Dual senior authorship (JR and BCF contributed equally to this article).

Copyright © 2021. SEP y SEPB
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos